Biotech Companies Flood Public Markets With IPOs Over $900 Million


"Four biotechnology companies went public on Friday under the guidance of nine law firms, overcoming market turbulence to raise $932 million in mostly upsized initial public offerings that priced at peak range or better."

Read the article (subscription required)

Related Contacts
Charlie Kim Partner San Diego, Los Angeles
Related Practices & Industries

Capital Markets Life Sciences